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Abstract 
Angiolymphoid hyperplasia with eosinophilia (ALHE) is a rare and idiopathic vascular 
disorder. It is characterized by red to brown papules or nodules dislocated in the dermis 
or subcutaneous tissue. These lesions are typically localized on the head and neck, 
particularly around the ear as singular or multiple nodules. Although ALHE is a benign 
disease, lesions are often persistent and difficult to eradicate. ALHE can occur in all races, 
but it is reported more frequently in Asians. Young to middle-aged women are more 
commonly affected. The histological examination corresponds to a florid vascular 
proliferation with atypical endothelial cells surrounded by a lymphocytic and 
eosinophilic infiltrate. We describe the case of a 67-year-old Caucasian man with a 
nodular lesion in the right postauricular region for 3 years. The histological examination 
was consistent with ALHE. Monthly intralesional corticosteroid injections were 
performed for 6 months, and complete remission was achieved. After 10 years of follow-
up, the patient is free of recurrence. 
 
Introduction 
Angiolymphoid hyperplasia with eosinophilia (ALHE) or epithelioid hemangioma is 
an uncommon vascular disorder. Inflammatory processes such as allergic reactions, 
traumas or autoimmune disorders are identified as possible causes. ALHE can occur in all 
races, but it is reported more frequently in Asians. Young to middle-aged women are  
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more commonly affected. Typically, ALHE patients present with smooth-surface red to 
brown papules or nodules on the head and neck; most nodules are localized near the ear. 
Other less common sites include the trunk, extremities, genitalia, lips and oral mucosa; 
extracutaneous involvement is rare [1, 2]. 
The main differential diagnosis is Kimura disease [3], but other disorders such as facial 
granuloma, insect bite reaction, cutaneous lymphoma or sarcoidosis may imitate the 
clinical picture of ALHE [2]. 
Case Report 
A 67-year-old Caucasian man was referred to our outpatient clinic with a 3-year history of an 
erythematous, elastic, hard nodular lesion in the right postauricular area (fig. 1). The lesion had 
gradually increased in size, measuring 3 × 6 cm at our first observation; intense itch was reported. 
Topical corticosteroid treatment had not led to any improvement. Routine laboratory investigations 
were negative. A 4-mm punch biopsy was performed, and histologic analysis showed a florid vascular 
proliferation with atypical endothelial cells surrounded by lymphocytic and eosinophilic infiltrate (fig. 
2a–d). Immunohistochemistry showed CD34-positive epithelioid cells (fig. 2c). 
Based on these observations, a diagnosis of ALHE was made. Abdominal scan excluded any internal 
involvement. We decided to treat the patient with intralesional corticosteroid injections: 2 ml of 
triamcinolone acetonide (20 mg/ml) once a month for 6 months. No additional topical treatment was 
given. The lesion gradually decreased and completely disappeared at the 7th month. The patient 
attended our clinic for follow-up visits every second month for the first year after the remission, then 
every 6 months for 2 years. Since then, clinical evaluation has been performed every year. At 10-year 
follow-up there was no evidence of recurrence. 
Discussion 
ALHE can have a spontaneous remission over the course of months or years, but 
symptomatic and disfiguring lesions may require treatment [4]. Multiple treatments have 
been proposed for disease management. Surgical excision is the treatment of choice, but 
as the lesions are often multilobulated and poorly delineated, local recurrences occur in 
33–50% after standard surgical excision. Mohs micrographic surgery with complete 
margin examination has been considered [5]. However, surgery can be disfiguring and 
difficult, especially in the case of periauricular lesions. Thus, other treatment options may 
be helpful; they include radiotherapy, curettage, shave excision with electrodessication, 
cryotherapy [6], corticosteroids (topical, systemic or intralesional preparation), and laser 
therapy. Continuous wave carbon dioxide and argon lasers have been successfully used, 
but there is a risk of scarring after treatment. Anecdotal reports have described other 
successful therapeutic options: intralesional interferon alpha-2a [7], indomethacin 
farnestil, pentoxifylline, chemotherapeutic agents such as vinblastine, mepolizumab (anti-
interleukine-5) and imiquimod [8, 9]. Furthermore, oral retinoids have been employed 
with different results [2]. 
Although all these innovative treatments have been reported for ALHE management, 
we would like to highlight this case because it could encourage the treatment with 
intralesional corticosteroids, which is a traditional therapeutic approach that still offers 
the advantage of being simple to perform and much less invasive than a surgical 
approach, while it achieves similar results in terms of recurrences and even better 
aesthetic outcomes.  
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Fig. 1. Erythematous nodular lesion on the right subauricular area in a 67-year-old man. 
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Fig. 2. Skin biopsy specimen from the lesion: hematoxylin-eosin stain, original magnification × 200 (a, 
b), ×400 (d), and CD34 immunohistochemical staining (c). a Immature vessels with single-layer 
endothelial cells surrounded by pericytes. b Enlarged endothelial cells with big ovoid nuclei and 
abundant eosinophilic cytoplasm protruding into the vascular lumen with a tendency to restrict or 
obstruct it. c CD34-positive epithelioid cells. d Mixed inflammatory infiltrate in the reticular dermis: 
lymphocytes, eosinophils and lymphoid aggregates with follicle formations. 
 
References 
1  Endo M, Shibata M, Iwamoto I, Suzuki H, Hayakawa M: Angiolymphoid hyperplasia with eosinophilia. Eur J 
Dermatol 1998;8:175–177. 
2  El Sayed F, Dhaybi R, Ammoury A, Chababi M: Angiolymphoid hyperplasia with eosinophilia: efficacy of 
isotretinoin? Head Face Med 2006;2:32–36. 
3  Chun SI, Ji HG: Kimura’s disease and angiolymphoid hyperplasia with eosinophilia: clinical and 
histopathologic difference. J Am Acad Dermatol 1992;27:954–958. 
4  Kaur T, Sandhu K, Gupta S, Kanwar AJ, Kumar B: Treatment of angiolymphoid hyperplasia with eosinophilia 
with the carbon dioxide laser. J Dermatol Treat 2004;15:328–330. 
5  Miller CJ, Ioffreda MD, Ammirati CT: Mohs micrographic surgery for angiolymphoid hyperplasia with 
eosinophilia. Dermatol Surg 2004;30:1169–1173. 
6  Wozniacka A, Omulecki A, Torzecka JD: Cryotherapy in the treatment of angiolymphoid hyperplasia with 
eosinophilia. Med Sci Monit 2003;9:CS1–CS4. 
7  Shenefelt PD, Rinker M, Caradonna S: A case of angiolymphoid hyperplasia with eosinophilia treated with 
intralesional interferon alpha. Arch Dermatol 2000;136:837–839. 
8  Braun-Falco M, Fischer S, Prötz SG, Ring J: Angiolymphoid hyperplasia with eosinophilia treated with anti-
interleukin-5 antibody (mepolizumab). Br J Dermatol 2004;151:1103–1104. 
9  Redondo P, Del Olmo J, Idoate M: Angiolymphoid hyperplasia with eosinophilia successfully treated with 
imiquimod. Br J Dermatol 2004;151:1110–1111. 